跳至主要内容
临床试验/NCT00948363
NCT00948363已完成不适用

The Effect of Kiwi on Blood Pressure, Endothelial Function, Antioxidant Capacity and Gene Expression in Mildly Hypertensive Subjects

Oslo University Hospital2 个研究点 分布在 1 个国家目标入组 118 人开始时间: 2009年8月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
118
试验地点
2
主要终点
Blood pressure

研究概览

简要总结

The purpose of this study is to determine whether the intake of kiwi fruits will reduce systolic and diastolic blood pressure compared to intake of apples. The investigators hypothesize that the increased intake lutein or other components in the kiwi fruit will enhance nitric oxide bioavailability and lead to vascular relaxation.

详细描述

An interesting finding in the Oslo Antioxidant Study was that intake of 3 kiwi fruits reduced blood pressure in a clinical significant manner compared to controls. The mechanism for the blood pressure reducing effect of kiwi or the responsible components are not elucidated. However, plasma lutein levels and antioxidant capacity measured by the ferric reducing antioxidant power was increased in the kiwi group. Moreover, gene expression was also altered by the increased intake of kiwi.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
35 Years 至 69 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Systolic blood pressure 130-159 mmHg
  • •Diastolic blood pressure 85-99 mmHg
  • •Body mass index <35 kg/m2

排除标准

  • •Systolic blood pressure >160 mmHg or <129 mmHg
  • •Diastolic blood pressure >100 mmHg or <84 mmHg
  • •Current use or need for blood pressure lowering medication
  • •Symptomatic cardiovascular disease, diabetes, renal dysfunction, psychiatric disorder, pregnancy or lactation, history of obesity surgery.

研究组 & 干预措施

Kiwi fruits

Active Comparator

干预措施: Kiwi fruits (Other)

Apple

Placebo Comparator

干预措施: Apple (Other)

结局指标

主要结局

Blood pressure

时间窗: 8 weeks

次要结局

  • Endothelial function(8 weeks)

研究者

发起方
Oslo University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Tor Ole Klemsdal

Chief Consultant

Oslo University Hospital

研究点 (2)

Loading locations...

相似试验